Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc.
Plaintiff: Novartis Pharmaceuticals Corporation and Novartis AG
Defendant: Mylan Pharmaceuticals Inc.
Case Number: 1:2019cv00120
Filed: June 6, 2019
Court: US District Court for the Northern District of West Virginia
Presiding Judge: Irene M Keeley
Nature of Suit: Patent - Abbreviated New Drug Applications (ANDA)
Cause of Action: 35:271
Jury Demanded By: None
Docket Report

This docket was last retrieved on June 11, 2019. A more recent docket listing may be available from PACER.

Date Filed Document Text
June 11, 2019 Opinion or Order Filing 9 ORDER granting #7 Motion for Leave to Appear Pro Hac Vice for Attorney Nicholas N. Kallas. Signed by Senior Judge Irene M. Keeley on 6/11/2019. (jmm)
June 11, 2019 Filing 8 Pro Hac Vice Filing fee as to Nicholas N. Kallas: PAID $ 200.00, receipt number WVNC002628. (wrr)
June 11, 2019 Filing 7 MOTION for Leave to Appear Pro Hac Vice of Nicholas N. Kallas by Novartis AG, Novartis Pharmaceuticals Corporation. (Attachments: #1 Text of Proposed Order)(Companion, James)
June 6, 2019 Filing 6 VERIFICATION OF ATTORNEY ADMISSION.(sent via email) (jmm)
June 6, 2019 Filing 5 Corporate Disclosure Statement by Novartis AG. (jmm)
June 6, 2019 Filing 4 Corporate Disclosure Statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (jmm)
June 6, 2019 Filing 3 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (jmm)
June 6, 2019 Filing 2 Filing fee: $ 400.00, receipt number WVNW002198. (jmm)
June 6, 2019 Filing 1 COMPLAINT against Mylan Pharmaceuticals Inc., filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: #1 Exhibit A Patent Number 5,665,772, #2 Exhibit B Patent Number US 8,778,962 B2, #3 Exhibit C Patent No. US 8,436,010 B2, #4 Suppleement Information for Patenet Cases Involving An Abbreviatd New Drug Appliation (ANDA), #5 Civil Cover Sheet)(jmm)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the West Virginia Northern District Court's Electronic Court Filings (ECF) System

Search for this case: Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Pharmaceuticals Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novartis Pharmaceuticals Corporation
Represented By: James F. Companion
Represented By: Nicholas N. Kallas
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novartis AG
Represented By: James F. Companion
Represented By: Nicholas N. Kallas
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?